EN DE
Watch Lagis Enterprise Co., Ltd. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Lagis Enterprise Co., Ltd. (6730) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Lagis Enterprise Co., Ltd. stock TWD 23.27, price TWD 32.10, that is 27.5% below the price, quality 45 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TW · ISIN TW0006730005

LE Lagis Enterprise Co., Ltd. logo Thin data Nov 9, 2026

Lagis Enterprise Co., Ltd.

6730 · TWO
Expensive, weak quality

Our calculation puts a fair price 27% below what the stock costs today.

Solidly profitable · 14.0% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (9/14)
Quality 45/100
Expensive Growth (revenue 5y +8.8 %/yr in TWD)
4.7% dividend yield · Watch coverage
Moderate moat 54/100 · thin data
Fair value 23.27 TWD · Overvalued
Thin data
⚠ Dilution
Watch Lagis Enterprise Co., Ltd. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

48.20 TWD 25.48 TWD Fair Value 23.27 TWD Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range 25.48 TWD – 48.20 TWD · fair‑value band 12.40 TWD – 36.50 TWD · the 32.10 TWD price screens above the 23.27 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.

Follow Lagis Enterprise Co. in your weekly email

Every Wednesday you see whether Lagis Enterprise Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China.

Show moreShow less

Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and irrigation pumps; electrosurgery system; endo endoscopic instruments, include scissors and dissectors, graspers, mini laparoscopy grasping device, and laparoscopic electrode; and retrieval specimen bags.

The company sells its products under LAGIS brand name. Lagis Enterprise Co., Ltd. was founded in 2004 and is headquartered in Taichung, Taiwan.

Stock analysis

Lagis Enterprise Co., Ltd. (6730) currently trades at 32.10 TWD, while our model-based Fair Value estimate is 23.27 TWD, 27% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 39.21 TWD per share, and 9 of the 26 models we run sit above the 32.10 TWD price.

Bear case: the Asset-Based group reads lowest at 14.02 TWD, and 17 of the 26 models stay below the price. Data coverage for this calculation is low.

Scenario range: 12.40 TWD (bear) to 36.50 TWD (bull), the price of 32.10 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Lagis Enterprise Co., Ltd. reported revenue of 488M TWD in FY2025 versus 393M TWD in FY2021, a compound +5.5%/yr. Reported net income was 69.3M TWD in FY2025, compounding +9.1%/yr from FY2021.

Key figures

Market cap 1.2B TWD (≈ $35.5M) Micro · P/E ratio 16.2 · P/S ratio 2.37 · EPS (TTM) 1.98 TWD · Dividend yield 4.7% · Net margin 14.0% · Return on equity 10.4% · Return on assets (EBIT) 9.6% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (low confidence).

What moves the price

The share trades about 26% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −27%, 6730 screens cheaper than that median.

Fair Value models

Bear 12.40 TWD Fair Value 23.27 TWD Bull 36.50 TWD
Price 32.10 TWD · Downside -27.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.4116 TWD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 8.54 TWD 15.43 TWD 25.79 TWD 78
Growth DCF 8.80 TWD 14.96 TWD 23.69 TWD 77
Residual Income 18.12 TWD 19.77 TWD 23.58 TWD 76
All 26 models by family
DCF Models
FCF DCF 8.54 TWD 15.43 TWD 25.79 TWD 78
Owner Earnings 8.15 TWD 14.82 TWD 24.87 TWD 74
5Y Revenue Exit 13.72 TWD 25.78 TWD 41.19 TWD 71
5Y EBITDA Exit 21.88 TWD 40.88 TWD 63.01 TWD 73
5Y P/E Exit 18.26 TWD 34.17 TWD 50.76 TWD 69
10Y Revenue Exit 11.05 TWD 21.59 TWD 35.71 TWD 64
10Y EBITDA Exit 16.89 TWD 32.01 TWD 52.20 TWD 66
10Y P/E Exit 14.59 TWD 27.38 TWD 42.94 TWD 62
Earnings-Based
Graham-Dodd 12.98 TWD 38.21 TWD 50.54 TWD 65
Lynch FV 8.00 TWD 11.43 TWD 14.86 TWD 61
PEG = 1.0 8.00 TWD 11.43 TWD 14.86 TWD 57
EPV 14.19 TWD 17.29 TWD 20.01 TWD 74
Dividend Discount
Gordon GGM 8.12 TWD 16.89 TWD 26.80 TWD 66
DDM Multi-Stage 8.12 TWD 13.11 TWD 17.72 TWD 66
Multiples
P/E Multiple 31.49 TWD 41.98 TWD 52.48 TWD 63
P/S Multiple 24.33 TWD 32.44 TWD 40.55 TWD 58
P/B Multiple 33.66 TWD 44.88 TWD 56.10 TWD 55
EV/EBIT 26.14 TWD 36.43 TWD 46.72 TWD 66
EV/EBITDA 33.06 TWD 45.66 TWD 58.26 TWD 67
EV/Revenue 17.30 TWD 26.75 TWD 36.19 TWD 53
Asset-Based
NCAV (Graham) 10.46 TWD 14.02 TWD 20.93 TWD 54
Growth DCF
Growth DCF 8.80 TWD 14.96 TWD 23.69 TWD 77
Rev-Margin DCF 13.72 TWD 25.67 TWD 39.13 TWD 71
Economic Profit
Residual Income 18.12 TWD 19.77 TWD 23.58 TWD 76
ROIC Compounder 14.19 TWD 17.29 TWD 20.01 TWD 72
Growth Earnings
Growth-Adj P/E 25.44 TWD 36.34 TWD 47.24 TWD 67

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 45/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 51
Are margins and returns getting better?
Cashflow 57
Do the profits arrive as real cash?
Financial strength 81
Debt, balance sheet and risk of trouble
Investment 15
Does it invest with discipline instead of growing at any price?
Low Volatility 81
How calm the share price moves, does not count
Price momentum 21
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 23
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.1%
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+9.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.7%
Dividend (yield on the price)4.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 18%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+17.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +15.8% a year for the price.

6730 screens overvalued: fair value 27% below the price. Compare with Intuitive Surgical, Inc →

Compare Lagis Enterprise Co., Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks

Beats the industry median on 9/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 45 · Bottom 25%
Fair Value upside −27.7% · Below median
Profitability
Return on equity (12 months) 10.4% · Above median
Return on assets 6.1% · Above median
Net margin (12 months) 14.0% · Above median
Operating margin (12 months) 14.9% · Above median
Growth and dividend
Revenue growth (quarter YoY) 4.8% · Below median
Dividend yield (12 months) 4.7% · Top 25%
Balance sheet
Debt / equity 0.34× · Highest 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (12 months) 16.2× · Cheaper than median
P/B 1.53× · Cheaper than median
P/S (12 months) 2.37× · Cheaper than median
Price / free cash flow (fiscal year) 29.5× · Pricier than median
EV/EBITDA 10.1× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 25
FUTURE (revenue growth)24 · sector 40
PAST (return on equity)42 · sector 30
HEALTH (low debt)83 · sector 96
DIVIDEND (yield)93 · sector 32

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.38 $131.27 +45% vs 6730
EssilorLuxottica Société anonyme EL €193.80 €196.22 +1% vs 6730
Intuitive Surgical, Inc ISRG $452.80 $353.90 −22% vs 6730
Medline Inc MDLN $39.64 $28.59 −28% vs 6730
Alcon Inc ALC CHF 61.30 CHF 34.06 −44% vs 6730
Becton, Dickinson and Company BDX $211.88 $97.80 −54% vs 6730
Straumann Holding STMN CHF 104.50 CHF 45.50 −56% vs 6730
West Pharmaceutical Services, Inc WST $399.81 $139.22 −65% vs 6730
Sartorius Stedim Biotech S.A DIM €225.80 €54.82 −76% vs 6730
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs 6730

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Lagis Enterprise Co., Ltd.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Lagis Enterprise Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6730

Frequently asked questions

Is Lagis Enterprise Co., Ltd. (6730) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 23.27 TWD versus a price of 32.10 TWD, about 27% lower (overvalued).
What is the fair value of 6730?
Our model-based fair value for Lagis Enterprise Co., Ltd. is 23.27 TWD (as of Nov 9, 2026), built from audited fundamentals. The current price: 32.10 TWD.
What is the quality score of 6730?
Lagis Enterprise Co., Ltd. has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lagis Enterprise Co., Ltd. (6730)?
Our model-based price target is the fair value of 23.27 TWD (as of Nov 9, 2026) from 26 valuation models. Cautious scenario 12.40 TWD, optimistic scenario 36.50 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Lagis Enterprise Co., Ltd. stock forecast for 2026?
Our models put fair value at 23.27 TWD, about 27% lower versus a price of 32.10 TWD (overvalued). Cautious scenario 12.40 TWD, optimistic scenario 36.50 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Lagis Enterprise Co., Ltd. (6730)?
Lagis Enterprise Co., Ltd. reported trailing-twelve-month revenue of about 492M TWD (latest available figure, as of Nov 9, 2026).
Does Lagis Enterprise Co., Ltd. pay a dividend?
Lagis Enterprise Co., Ltd. currently shows a dividend yield of 4.67% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Lagis Enterprise Co., Ltd. (6730) and when is the ex-dividend date?
Lagis Enterprise Co., Ltd. pays a dividend of 1.50 TWD per share a year, a dividend yield of 4.7%. The last ex-dividend date was Jul 6, 2026. A dividend has been paid every year since at least 2020. The payout ratio is 75.8% of earnings. Free cash flow covers the dividend 0.73 times. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What growth is priced into Lagis Enterprise Co., Ltd. (6730)?
For today's price to be fair in a discounted-cash-flow model, Lagis Enterprise Co., Ltd. would have to grow free cash flow by +17.6 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.8 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of 6730 use?
Our models discount Lagis Enterprise Co., Ltd. at 9.0 %: a base by market capitalisation (nano), damped by beta 0.18, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lagis Enterprise Co., Ltd. that is +17.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Lagis Enterprise Co., Ltd. (6730) delivered so far?
Over the past 5 years revenue at Lagis Enterprise Co., Ltd. grew +8.8 % a year. The price currently implies free-cash-flow growth of +17.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lagis Enterprise Co., Ltd. (6730) growing?
The median revenue growth in the sector is +1.7 % a year. That is the yardstick for the growth priced into Lagis Enterprise Co., Ltd. (+17.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lagis Enterprise Co., Ltd. (6730)?
The free-cash-flow yield on the price is 3.40 %: that much free cash flow Lagis Enterprise Co., Ltd. produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lagis Enterprise Co., Ltd. (6730)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lagis Enterprise Co., Ltd. it is 23.27 TWD per share (as of Nov 9, 2026), against a price of 32.10 TWD. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Lagis Enterprise Co., Ltd. stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 6730 trades above its calculated fair value: price 32.10 TWD, fair value 23.27 TWD, a gap of about −27% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6730?
No. The price is what the market pays today (32.10 TWD); the fair value is what the company's own numbers justify (23.27 TWD). For Lagis Enterprise Co., Ltd. the two are 8.83 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Lagis Enterprise Co., Ltd. worth?
The market values Lagis Enterprise Co., Ltd. at about 1.2B TWD (market capitalisation, as of Nov 9, 2026). Per share that is 32.10 TWD; our models calculate a fair value of 23.27 TWD per share.
What do the bullish and bearish scenarios say about 6730?
Our models span a range for Lagis Enterprise Co., Ltd.: cautious scenario 12.40 TWD, base 23.27 TWD, optimistic 36.50 TWD per share (as of Nov 9, 2026, price 32.10 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6730?
Lagis Enterprise Co., Ltd. trades at a price-to-earnings ratio of 16.2 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 23.27 TWD is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2020 to 2025), reported earnings: 18.9. Other multiples: P/B 1.5, P/S 2.4, EV/EBITDA 10.1.
How solid is the balance sheet of Lagis Enterprise Co., Ltd. (6730)?
Balance-sheet figures for Lagis Enterprise Co., Ltd. (as of Nov 9, 2026): return on equity 10.4%, debt of 0.34 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is 6730 from its 52-week high?
Lagis Enterprise Co., Ltd. trades at 32.10 TWD, about 26% below its 52-week high of 43.31 TWD and 3% above the low of 31.10 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 23.27 TWD is for.
Which stocks are comparable to Lagis Enterprise Co., Ltd.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lagis Enterprise Co., Ltd. stock attractive at the current price?
The data as of Nov 9, 2026: price 32.10 TWD, calculated fair value 23.27 TWD (−27%), Quality Score 45/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6730 calculated?
We run Lagis Enterprise Co., Ltd. through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 23.27 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Lagis Enterprise Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lagis Enterprise Co., Ltd. (6730)?
The closing price on Nov 9, 2026 was 32.10 TWD. Our model-based fair value is 23.27 TWD, about 27% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lagis Enterprise Co., Ltd. right now?
Weak quality (45/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (12.40 TWD to 36.50 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Lagis Enterprise Co., Ltd.

How large is the market capitalisation of Lagis Enterprise Co., Ltd. (6730)?
The market capitalisation of Lagis Enterprise Co., Ltd. is 1.2B TWD (≈ $35.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lagis Enterprise Co., Ltd. (6730)?
The price-to-sales ratio of Lagis Enterprise Co., Ltd. is 2.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lagis Enterprise Co., Ltd. (6730)?
Earnings per share at Lagis Enterprise Co., Ltd. are 1.98 TWD (price ÷ EPS = P/E 16.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Lagis Enterprise Co., Ltd. (6730)?
The dividend yield of Lagis Enterprise Co., Ltd. is 4.7% (payout 75.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Lagis Enterprise Co., Ltd. (6730)?
The net margin of Lagis Enterprise Co., Ltd. is 14.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lagis Enterprise Co., Ltd. (6730)?
The return on equity (ROE) of Lagis Enterprise Co., Ltd. is 10.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lagis Enterprise Co., Ltd. (6730)?
On an EBIT basis the return on assets of Lagis Enterprise Co., Ltd. is 9.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lagis Enterprise Co., Ltd. (6730)?
The operating margin of Lagis Enterprise Co., Ltd. is 14.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lagis Enterprise Co., Ltd. (6730)?
Revenue at Lagis Enterprise Co., Ltd. is growing +4.8% versus a year earlier (3y avg +3.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lagis Enterprise Co., Ltd. (6730)?
Earnings per share at Lagis Enterprise Co., Ltd. are growing −6.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Lagis Enterprise Co., Ltd. (6730) carry?
The net debt of Lagis Enterprise Co., Ltd. is 172M TWD (fiscal year 2025, ≈ 4.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Lagis Enterprise Co., Ltd. in the live analysis

One click puts Lagis Enterprise Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.